The problems that fascinate us on a daily basis
applied
microbiology
research
lab
Our lab works towards a systems understanding of pathogen transmission: integrating host, pathogen and environmental aspects.
We combine patient cohorts with novel technologies to have an innovative translational research setting. In vitro and in vivo data is further used in computational models.
Our newest Blog-Posts
Adrian's new role in Karolinska University
Exciting news! Adrian was appointed on behalf of the Committee for Research at Karolinska Institutet in Stockholm, Sweden, as Foreign Adjunct Professor in Artificial Intelligence-based Diagnostics in Medical Microbiology at the Department of Laboratory Medicine, Karolinska Institutet. The appointment spans three years, from July 1, 2025, to June 30, 2028. He will work with Christian Giske's group to develop new diagnostic approaches. See also Adrian's LinkedIn post here.
AMR lab retreat 2025
We had an exciting two-day annual lab retreat at the Musikinsel. This retreat was filled with fun games, swimming in the Rhine, creative thinking, and scientific discussions. The heat wave tried to roast us, but we took a detour with the Rhine river boat tour!
Research Highlight: Largest Diphtheria Outbreak in Western Europe in 70 Years
A recent study published in the prestigious New England Journal of Medicine (NEJM), involving our group, has analyzed the largest diphtheria outbreak in Western Europe since the 1950s. The study revealed that the rise in infections observed among migrants across Europe in 2022 was linked to multiple genetically distinct strains of Corynebacterium diphtheriae, suggesting repeated introductions along common migration routes.
The collaborative work, involving 10 European countries, highlights the importance of rapid international coordination and genomic surveillance. The researchers identified antibiotic-resistant strains, underscoring the need for vigilant public health measures and updated vaccination efforts.
For further reading, visit the full article at NEJM, and additionally, in the University of Zurich news.
VITA Label Awarded to Our GvHD Biobank - 100th in Switzerland!
We’re excited to share that our biobank for the GvHD study has been awarded the VITA label by the Swiss Biobanking Platform - making it the 100th certified biobank in Switzerland!
This certification reflects our commitment to high-quality biobanking practices. The VITA label ensures that our processes meet national standards for traceability, sustainability, and data governance.
We thank the Swiss Biobanking Platform for their support and are proud to contribute to a network of biobanks enabling impactful biomedical research. A heartfelt thank you to our incredible team for your hard work and commitment to the GvHD study!
Learn more: https://swissbiobanking.ch/quality/vita/
